Medifocus Announces Filing of Annual Financial Statements and Applications to Have Cease Trade Orders Revoked and Trading Rei...
August 19 2011 - 6:52PM
Marketwired
Medifocus Inc. (Medifocus or the Company) (TSX VENTURE: MFS)(OTCQX:
MDFZF) announces that it has filed today its Financial Statements
for the year ended March 31, 2011, related Management's Discussion
and Analysis and other related annual filings. These documents will
be available for consultation under the Company's profile on SEDAR
at www.sedar.com.
Medifocus will apply for the revocation of the cease trade
orders respectively issued by the Ontario Securities Commission on
August 16, 2011 and the British Columbia Securities Commission on
August 9, 2011. The Company will also apply to the TSX Venture
Exchange for trading of its common shares to be reinstated.
Medifocus also confirms that there is no undisclosed material
change or material fact respecting its affairs.
About Medifocus Inc.
Medifocus owns a patented microwave focusing technology platform
(the Adaptive Phased Array (APA) technology), which can precisely
target and control microwave energy to cause heating in cancerous
tumors anywhere in the body reliably and repeatedly. The ability to
target tumors with a precision controlled dose of heat can be used
to destroy tumors at higher temperatures, to treat tumors in
combination with chemotherapy and/or radiation at moderate
temperatures for increased effectiveness and reduced toxicity and
to trigger the targeted release of therapeutic drugs and genes at
tumor sites at lower temperatures. While the core technology has
been licensed from the Massachusetts Institute of Technology,
Medifocus has further refined the precision of the microwave
focusing and control ability and developed a commercial system
dedicated exclusively for the treatment of Breast Cancer. Please
visit www.medifocusinc.com for more details.
Forward-Looking Statements and Information
This news release contains forward-looking statements, which may
not be based on historical facts. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause the actual results events or developments to be
materially different from any future results, events or
developments expressed or implied by such forward-looking
statements. These factors should be considered carefully and
readers are cautioned not to place undue reliance on such
forward-looking statements. Except as required under applicable
securities laws, the Company disclaims any obligation to update any
such factors or to publicly announce the results of any revisions
to any of the forward-looking statements contained herein to
reflect future results, events or developments.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: Medifocus Inc. John Mon (410) 290-5734
jmon@medifocususa.com www.medifocusinc.com
Medifocus (CE) (USOTC:MDFZF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medifocus (CE) (USOTC:MDFZF)
Historical Stock Chart
From Jul 2023 to Jul 2024